Pamisel Obtains Patent Rights for 'Bone Marrow-Derived Monocyte Production Method'

[Asia Economy Reporter Kum Boryeong] Pharmicell announced on the 18th that it has acquired a patent right related to the 'Bone Marrow-Derived Monocyte Manufacturing Method.'

Pharmicell stated, "Using this manufacturing method improves the yield of monocytes. It not only enhances the differentiation ability into immature dendritic cells, but also the mature dendritic cells developed from immature dendritic cells have improved immune functions. It can be usefully applied to manufacture dendritic cells for anticancer immune cell therapy," adding, "We plan to apply it to the development of next-generation anticancer immune cell therapy platforms, including treatments for prostate cancer, ovarian cancer, and pancreatic cancer."

This content was produced with the assistance of AI translation services.